다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
AMEX
Timber Pharmaceuticals Inc (TMBR)
Timber Pharmaceuticals Inc (TMBR) 뉴스

TMBR

Timber Pharmaceuticals (TMBR)

Timber Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:TMBR

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/11/29	07:21	GlobeNewswire Inc.	Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/09/19	05:05	GlobeNewswire Inc.	Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/08/21	21:00	GlobeNewswire Inc.	Timber Pharmaceuticals to be Acquired by LEO Pharma	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/07/04	05:05	GlobeNewswire Inc.	Timber Pharmaceuticals Discloses Communication From NYSE American	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/06/20	21:00	GlobeNewswire Inc.	Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/06/05	21:00	GlobeNewswire Inc.	Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/05/16	05:15	GlobeNewswire Inc.	Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/04/01	05:28	GlobeNewswire Inc.	Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/03/20	21:00	GlobeNewswire Inc.	Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/02/24	22:00	GlobeNewswire Inc.	Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/12/14	22:30	GlobeNewswire Inc.	Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward Outlook	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/12/10	06:05	GlobeNewswire Inc.	Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/14	22:00	GlobeNewswire Inc.	Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial Results	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/09	22:20	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/09	06:38	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/09	02:09	GlobeNewswire Inc.	Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock Split	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/03	21:42	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/03	21:22	GlobeNewswire Inc.	Timber Pharmaceuticals Announces Halt of Common Stock Trading	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/26	21:40	TipRanks	Analysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), Timber Pharmaceuticals (TMBR)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/25	21:31	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/25	21:00	GlobeNewswire Inc.	Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive Ichthyosis	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/04	05:16	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/03	23:56	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/03	22:00	GlobeNewswire Inc.	Timber Pharmaceuticals Announces $1.3 Million Registered Direct Offering	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/09/14	21:00	GlobeNewswire Inc.	Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital Ichthyosis	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/09/13	05:43	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/09/03	05:17	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/08/30	05:17	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/08/30	05:05	GlobeNewswire Inc.	Timber Pharmaceuticals Announces Notification of NYSE American Continued Listing Deficiency	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/08/29	21:00	GlobeNewswire Inc.	Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV Congress	AMEX:TMBR	Timber Pharmaceuticals Inc

검색 관련기사 보기:AMEX:TMBR

1 2 3 4 5 6 7 다음 >>

Mayr Melnhof Karton (PK)

PETRL310 Ex:28,12

Hsbc Usa Inc Capped Poin...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관